INDIANAPOLIS (WISH) – Here’s a look at Tuesday’s business headlines.
Indiana officials say health care services provider Pharmacord plans to build operations and call center in Jeffersonville.
It will create up to 850 jobs by the end of 2023.
The Louisville-based company expects to invest more than $52 million to launch its Indiana operations.
The FDA approved non-insulin Type 2 diabetes drug for kids, the first to hit the market in 20 years.
It has been approved for adults but not kids until now.
Researchers say the expanded indication provides an additional treatment option at a time when an increasing number of children are being diagnosed with the disease.
More than 5,000 new cases of Type 2 diabetes are now diagnosed each year in the U.S. among people younger than 20.
Many parents worry that their kids spend too much time on social media, videogames and other digital technology.
Pediatricians tell the Wall Street Journal the red flags for parents include disruptions in kids’ sleep, socializing and outside interests.
Doctors also note that overuse of digital media often accompanies an underlying condition such as anxiety or ADHD.
The U.S. women’s soccer team generated more revenue through mostly ticket sales since 2016 than the men’s team, according to the Wall Street Journal.
Women’s games brought in %50.8 million from 2016 to 2018, while men’s games made $49.9 million in the same time frame. But female players get paid significantly less than men, the women’s team claims in a lawsuit against the U.S. Soccer Federation.